BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2835726)

  • 21. Tissue reconstitution models of breast cancer.
    Edwards PA
    Cancer Surv; 1993; 16():79-96. PubMed ID: 8348540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
    Blair DG; Cooper CS; Oskarsson MK; Eader LA; Vande Woude GF
    Prog Clin Biol Res; 1983; 119():79-90. PubMed ID: 6346333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenesis by mutations in anti-oncogenes: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; Derkinderen DJ; De Graaf PW; Huber J; Lips CJ; Roholl PJ
    Anticancer Res; 1990; 10(2B):475-87. PubMed ID: 2190526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Model systems of carcinogenesis in vitro: the interaction of the ras oncogene with immortalized cells].
    Topol' LZ; Spitkovskiĭ DD; Kiselev FL
    Biull Eksp Biol Med; 1988 Mar; 105(3):329-32. PubMed ID: 3280050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
    Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice.
    Marks J; Lin J; Miller D; Lozano G; Herbert J; Levine AJ
    Prog Clin Biol Res; 1988; 284():163-86. PubMed ID: 2851142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).
    Van Dyck F; Declercq J; Braem CV; Van de Ven WJ
    Int J Oncol; 2007 Apr; 30(4):765-74. PubMed ID: 17332914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditioned tumorigenicity of activated oncogenes.
    Klein G; Klein E
    Cancer Res; 1986 Jul; 46(7):3211-24. PubMed ID: 3011242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J; Morello D
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-methyl-N-nitrosourea-induced transformation of rat urothelial cells in vitro is not mediated by activation of ras oncogenes.
    Knowles MA; Eydmann ME; Proctor A; Padua RA; Roberts J
    Oncogene; 1987 May; 1(2):143-8. PubMed ID: 3325878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
    Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
    Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SV40 large T-antigen: dual oncogene.
    Butel JS
    Cancer Surv; 1986; 5(2):343-65. PubMed ID: 3022925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.